ICAR Webcast

ICAR 2016, video ricordo

6 giugno 2016
7 giugno 2016
8 giugno 2016

ICAR 2016 Opening Session

Introducing ICAR 2016
A. Gori (Monza), A. Lazzarin (Milano), F. Maggiolo (Bergamo)

Authorities’ welcome addresses
M.C. Messa, Magnifico Rettore Università Milano-Bicocca

Mauro Moroni Memorial Lecture

90-90-90: what has been accomplished and what is left to do
Michel Kazatchkine, Geneva CH

ICAR-CROI Awards 2016 for young Italian HIV Investigators

Round Table - Shaping the future of research: which perspectives for young researchers?
Moderator: Cesara Buonamici, Vicedirettore TG5, Roma
Andrea Gori - Professore Straordinario di Malattie Infettive, Università Milano-Bicocca
Giovanni Leonardi - Direttore Generale Ricerca e Innovazione in Sanità, Ministero della Salute
Maria Cristina Messa - Magnifico Rettore, Università Milano-Bicocca
Angela Santoni - Rappresentante nazionale italiano del MIUR nel Comitato Horizon

Keynote Lectures

	Failures and resistance to DAA-based therapies: an old, still always new, problem in antiviral therapy Carlo Federico Perno, Roma
	ARV: early treatment for the future goals Andrea Antinori, Roma

Symposium: HIV maintenance therapy: the switch seduction

	The LDR and STR debate Diego Ripamonti, Bergamo
	How to save toxicity Stefano Bonora, Torino
	Residual viraemia removal temptation Nicola Gianotti, Milano
	Discussion

Symposium: Host and virus: an ongoing affair

	Mucosal immunity Mirko Paiardini, Atlanta USA
	HIV restriction factors Manuela Sironi, Bosisio Parini LC
	Immunological predictors of viral rebound after treatment interruption John Frater, Oxford UK
	Discussion

Symposium: Emerging challenges in virologically controlled patients

	Beyond virological control Massimo Andreoni, Roma
	A normal life expectancy on cART: myth or reality Amanda Mocroft, London UK
	Coronary disease: from pathogenesis to treatment Antonella Castagna, Milano
	Discussion

Special Lecture

Zika: a diabolic juncture?
Giuseppe Ippolito, Roma

Keynote Lectures

	Value based medicine in Hepatitis Mario Strazzabosco, Milano
	HIV and MSM: community empowerment and the role of acute infection in halting the epidemics Michael Meulbroek, Barcelona E

Symposium: HCV 2016 update

	The liver disease beyond HCV cure Massimo Puoti, Milano
	Black holes in the DAAs therapy Alessio Aghemo, Milano
	Resistance to DAAs: emerging pictures form Italian experience Francesca Ceccherini-Silberstein, Roma
	Discussion

Symposium: Hepatitis B: the future

	HBV-specific immunity: lessons from animal models Luca Guidotti, Milano
	Therapy: molecular targets Massimo Levrero, Roma
	Therapy: immunological targets Carlo Ferrari, Parma
	Discussion

Symposium: Priorities and sustainability of the healthcare system: the stakeholders' view

	Overview Giovanni Fattore, Milano
	The economic scenario Emanuela Foglia, Castellanza VA
	The real HCV scenario Ivan Gardini, Vimercate MB
	People living with HIV proactive role Maria Rosaria Iardino, Milano
	Discussion

ICAR 2016 AWARDS

ICAR – SIMIT e ICAR – SIVIM
A. Gori (Monza), A. Lazzarin (Milano), F. Maggiolo (Bergamo)

Closing remarks

Closing remarks
A. Gori (Monza), A. Lazzarin (Milano), F. Maggiolo (Bergamo)